Passive and Active Polymer Coatings for Intracoronary Stents: Novel Devices to Promote Arterial Healing
Authors:
- 9 February 2009
- journal article
- review article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 22 (1) , 37-48
Abstract
Coronary stent implantation is the second great advance in the treatment of obstructive coronary artery disease since the introduction of balloon catheter angioplasty. However, in‐stent restenosis (ISR) caused by neointimal hyperplasia has been a major limitation of stents, occurring in up to 30% of cases. Advances in coronary stent technology both in terms of stent design and function and especially drug‐eluting stents (DES) have significantly improved the safety and efficacy of percutaneous coronary intervention (PCI) with stenting, including marked reduction in ISR. This has led to use of DES for increasingly challenging clinical and lesional subsets, with potential for increased risk of stent‐associated complications, especially late stent thrombosis (LST). Because restenosis and stent thrombosis are caused by multiple and often interrelated factors, ideal agents for stent coatings should inhibit thrombus formation, inflammatory reaction, and cellular proliferation, while supporting reendothelialization. To avoid undesirable effects of currently applied (durable) polymers, biocompatible, and bioabsorbable polymers as well as DES delivery systems that minimize polymer burden have been produced and tested. Bioabsorbable stents, both polymeric and metallic, have been developed to decrease potential late complications after stent implantation. Novel strategies to address some of these challenges are in various stages of research and development. In this article we outline developments in the field of passive and active stent coatings and evaluate the ongoing role of such coatings in the contemporary era of DES.Keywords
This publication has 56 references indexed in Scilit:
- Evaluation of a Novel Slow-Release Paclitaxel-Eluting Stent With a Bioabsorbable Polymeric Surface CoatingJACC: Cardiovascular Interventions, 2008
- Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human StudyThe American Journal of Cardiology, 2007
- Steroid-eluting stents in patients with acute coronary syndrome: the Dexamethasone Eluting Stent Italian REgistry: Table 1Heart, 2006
- Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitroExperimental Cell Research, 2004
- Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's long-term outcomeAmerican Heart Journal, 2003
- Effects of stent coating on platelets and endothelial cells after intracoronary stent implantationClinical Cardiology, 2001
- Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)The American Journal of Cardiology, 2000
- Phosphorylcholine-Coated Metallic Stents in Rabbit Iliac and Porcine Coronary ArteriesScandinavian Cardiovascular Journal, 1998
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984